Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized prospective study of dosing interval of medical abortion drugs in second-trimester termination
2007-003706-10Phase 4Completed
- Sponsor
- Maarit Mentula
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mifepristone + misoprostol in abortion (2 arms), sponsored by Maarit Mentula. Primary endpoints: Success of pregnancy termination and Complication rate. Started Oct 2007; status: completed.
02
Drugs
mifepristone + misoprostol
03
Conditions
abortion
Beyond the preview
Go deeper on 2007-003706-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003706-10.